# UCB

Source: https://onco.cc/companies/ucb/  
OnCo record `ucb` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

UCB is a Brussels pharmaceutical company focused on neurology and immunology whose cancer trials on the registry are mostly older programmes and supportive care studies.

## Summary

UCB is a Belgian biopharmaceutical company, listed on Euronext Brussels, whose marketed medicines are in epilepsy, immunology and rare diseases. Its subsidiaries UCB Biopharma SRL and UCB Pharma appear as lead sponsors of a number of phase 3 cancer trials on ClinicalTrials.gov, largely from earlier programmes and studies of supportive medicines; oncology is not part of its current core strategy. OnCo records it so that those trials resolve to a sponsor page.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: UCB Biopharma SRL; UCB Pharma; UCB S.A.; UCB Biopharma S.P.R.L.; UCB Biopharma; Ra Pharmaceuticals, Inc.; Ra Pharmaceuticals
- Tags: ctgov-sponsor
- HQ: Brussels
- Type: pharma
- Website: https://www.ucb.com

## Sources

- Official website: https://www.ucb.com
- ClinicalTrials.gov: trials led by UCB: https://clinicaltrials.gov/search?lead=UCB
- Wikipedia: https://en.wikipedia.org/wiki/UCB_(company)

## Connected records

- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)
- trials: [A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis](https://onco.cc/trials/nct06149559/), [A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis](https://onco.cc/trials/nct06055959/)

---
JSON: https://onco.cc/api/v1/entities/ucb.json